Ad is loading...
FNA
Price
$10.01
Change
+$0.31 (+3.20%)
Updated
Nov 15 closing price
101 days until earnings call
MDRSF
Price
$66.68
Change
-$0.00 (-0.00%)
Updated
Oct 21 closing price
Ad is loading...

FNA vs MDRSF

Header iconFNA vs MDRSF Comparison
Open Charts FNA vs MDRSFBanner chart's image
Paragon 28
Price$10.01
Change+$0.31 (+3.20%)
Volume$781.7K
CapitalizationN/A
MEDARTIS HOLDING AG
Price$66.68
Change-$0.00 (-0.00%)
Volume$500
CapitalizationN/A
FNA vs MDRSF Comparison Chart
Loading...
FNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
FNA vs. MDRSF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNA is a Sell and MDRSF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (FNA: $10.01 vs. MDRSF: $66.68)
Brand notoriety: FNA and MDRSF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FNA: 138% vs. MDRSF: 188%
Market capitalization -- FNA: $998.19M vs. MDRSF: $1.15B
FNA [@Medical Specialties] is valued at $998.19M. MDRSF’s [@Medical Specialties] market capitalization is $1.15B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FNA’s FA Score shows that 0 FA rating(s) are green whileMDRSF’s FA Score has 1 green FA rating(s).

  • FNA’s FA Score: 0 green, 5 red.
  • MDRSF’s FA Score: 1 green, 4 red.
According to our system of comparison, FNA is a better buy in the long-term than MDRSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FNA’s TA Score shows that 5 TA indicator(s) are bullish.

  • FNA’s TA Score: 5 bullish, 5 bearish.

Price Growth

FNA (@Medical Specialties) experienced а +40.00% price change this week, while MDRSF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

FNA is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDRSF($1.15B) has a higher market cap than FNA($998M). MDRSF YTD gains are higher at: -14.469 vs. FNA (-19.469). MDRSF has higher annual earnings (EBITDA): 11.7M vs. FNA (-26.92M). FNA has more cash in the bank: 75.6M vs. MDRSF (20.6M). MDRSF has less debt than FNA: MDRSF (27.5M) vs FNA (110M). FNA has higher revenues than MDRSF: FNA (216M) vs MDRSF (183M).
FNAMDRSFFNA / MDRSF
Capitalization998M1.15B87%
EBITDA-26.92M11.7M-230%
Gain YTD-19.469-14.469135%
P/E Ratio370.37N/A-
Revenue216M183M118%
Total Cash75.6M20.6M367%
Total Debt110M27.5M400%
TECHNICAL ANALYSIS
Technical Analysis
FNA
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
MACD
ODDS (%)
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
75%
Declines
ODDS (%)
Bearish Trend 25 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
FNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFALX27.14-0.14
-0.51%
DFA Large Cap International I
TSMWX16.77-0.19
-1.12%
Nuveen Quant Small/Mid Cap Eq R6
CECFX29.50-0.34
-1.14%
Columbia Large Cap Enhanced Core Adv
EMGRX11.09-0.13
-1.16%
Nuveen Small Cap Select A
WIREX19.21-0.51
-2.59%
Wireless

MDRSF and

Correlation & Price change

A.I.dvisor tells us that MDRSF and NHNKF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDRSF and NHNKF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDRSF
1D Price
Change %
MDRSF100%
N/A
NHNKF - MDRSF
28%
Poorly correlated
N/A
FNA - MDRSF
24%
Poorly correlated
+3.20%
OSUR - MDRSF
24%
Poorly correlated
-3.51%
MHUA - MDRSF
21%
Poorly correlated
-5.39%
ESMC - MDRSF
21%
Poorly correlated
N/A
More